| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |